Table 2 Distribution of patients with COPD by lung function.
LV Dysfunction | ||||
|---|---|---|---|---|
FEV1 | Mild LV dysfunction (LVEF>35%) | Moderate to severe LV dysfunction (LVEF<34%) | ||
Diprospan group | Placebo group | Diprospan group | Placebo group | |
50–70% | 22 | 23 | 4 | 4 |
35–49% | 2 | 2 | 1 | 1 |
< 34% | 1 | 0 | 0 | 0 |